Literature DB >> 27688803

Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice.

Jingchun Liu1, Manjula Santhanakrishnan1, Prabitha Natarajan1, David R Gibb1, Stephanie C Eisenbarth1,2, Christopher A Tormey1,3, Alexa J Siddon1,4, Sean R Stowell5, Donald R Branch6, Jeanne E Hendrickson1,7.   

Abstract

Red blood cell (RBC) alloimmunization is a serious complication of transfusion or pregnancy. Despite the widespread use of Rh immune globulin to prevent pregnancy associated anti-D alloimmunization, its mechanism of action remains elusive. We have previously described a murine model in which immunoprophylaxis with polyclonal anti-KEL sera prevents alloimmunization in wild-type recipients transfused with transgenic murine RBCs expressing the human KEL glycoprotein. To investigate the mechanism of action, we have now evaluated the outcome of immunoprophylaxis treatment in mice lacking Fcγ receptors (FcγRs), complement (C3), both, or none. Whereas polyclonal anti-KEL sera completely prevented alloimmunization in wild-type and single-knockout (KO) mice lacking FcγRs or C3, double-KO mice lacking both FcγRs and C3 became alloimmunized despite immunoprophylaxis. Rapid clearance of essentially all transfused RBCs with detectable KEL glycoprotein antigen occurred within 24 hours in wild-type and single-KO recipients treated with immunoprophylaxis, with the transfused RBCs remaining in circulation having minimal KEL glycoprotein antigen detectable by flow cytometry or western blot. In contrast, transfused RBCs with the KEL glycoprotein antigen fully intact continued to circulate for days in double-KO mice despite treatment with immunoprophylaxis. Further, in vitro phagocytosis assays showed no consumption of opsonized murine RBCs by double-KO splenocytes. Taken in combination, our data suggest that modulation of the KEL antigen (and potentially RBC clearance) by redundant recipient pathways involving both FcγRs and C3 may be critical to the mechanism of action of polyclonal anti-KEL immunoprophylaxis. These findings could have implications for the development of immunoprophylaxis programs in humans.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27688803      PMCID: PMC5201095          DOI: 10.1182/blood-2016-06-724732

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis).

Authors:  Belinda M Kumpel
Journal:  Immunol Lett       Date:  2002-06-03       Impact factor: 3.685

2.  CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes.

Authors:  R H Carter; D T Fearon
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

Review 3.  Red blood cell blood group antigens: structure and function.

Authors:  Marion E Reid; Narla Mohandas
Journal:  Semin Hematol       Date:  2004-04       Impact factor: 3.851

Review 4.  Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials.

Authors:  R Béliard
Journal:  Transfus Clin Biol       Date:  2006-04-03       Impact factor: 1.406

Review 5.  Fcgamma receptors as regulators of immune responses.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

Review 6.  Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.

Authors:  B M Kumpel
Journal:  Vox Sang       Date:  2007-08       Impact factor: 2.144

Review 7.  Antigen loss from antibody-coated red blood cells.

Authors:  James C Zimring; Chantel M Cadwell; Steven L Spitalnik
Journal:  Transfus Med Rev       Date:  2009-07

8.  Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-beta and prostaglandin E2.

Authors:  Donald R Branch; Fariba Shabani; Nicole Lund; Gregory A Denomme
Journal:  Transfusion       Date:  2006-08       Impact factor: 3.157

9.  IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?

Authors:  Davor Brinc; Hoang Le-Tien; Andrew R Crow; John Freedman; Alan H Lazarus
Journal:  Br J Haematol       Date:  2007-10       Impact factor: 6.998

Review 10.  Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn.

Authors:  B M Kumpel
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

View more
  15 in total

Review 1.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

2.  Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.

Authors:  Connie M Arthur; Jerry William L Allen; Hans Verkerke; Justin Yoo; Ryan P Jajosky; Kathryn Girard-Pierce; Satheesh Chonat; Patricia Zerra; Cheryl Maier; Jen Rha; Ross Fasano; Cassandra D Josephson; John D Roback; Sean R Stowell
Journal:  Blood Adv       Date:  2021-01-26

3.  Antibody-mediated immune suppression by antigen modulation is antigen-specific.

Authors:  Cheryl L Maier; Amanda Mener; Seema R Patel; Ryan P Jajosky; Ashley L Bennett; Connie M Arthur; Jeanne E Hendrickson; Sean R Stowell
Journal:  Blood Adv       Date:  2018-11-13

4.  Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcγ receptors in mice.

Authors:  Amanda Mener; Seema R Patel; Connie M Arthur; Sean R Stowell
Journal:  Transfusion       Date:  2018-11-26       Impact factor: 3.157

5.  Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model.

Authors:  David J Madrid; Manjula Santhanakrishnan; Jingchun Liu; David R Gibb; Dong Liu; Prabitha Natarajan; Daniel Beitler; Zhimin Shi; Chunyan Mo; Christopher A Tormey; Seema R Patel; Sean R Stowell; Jeanne E Hendrickson
Journal:  Blood Transfus       Date:  2018-11-07       Impact factor: 5.752

6.  Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy.

Authors:  Marianne E M Yee; Cassandra D Josephson; Anne M Winkler; Jennifer Webb; Naomi L C Luban; Traci Leong; Sean R Stowell; John D Roback; Ross M Fasano
Journal:  Transfusion       Date:  2018-04-17       Impact factor: 3.337

7.  Mice Immunized with IgG Anti-Sheep Red Blood Cells (SRBC) Together With SRBC Have a Suppressed Anti-SRBC Antibody Response but Generate Germinal Centers and Anti-IgG Antibodies in Response to the Passively Administered IgG.

Authors:  Joakim J E Bergström; Birgitta Heyman
Journal:  Front Immunol       Date:  2017-08-02       Impact factor: 7.561

8.  Complement Plays a Critical Role in Inflammation-Induced Immunoprophylaxis Failure in Mice.

Authors:  Vicente Escamilla-Rivera; Manjula Santhanakrishnan; Jingchun Liu; David R Gibb; James E Forsmo; Ellen F Foxman; Stephanie C Eisenbarth; C John Luckey; James C Zimring; Krystalyn E Hudson; Sean R Stowell; Jeanne E Hendrickson
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 8.786

9.  Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice.

Authors:  Vicente Escamilla-Rivera; Jingchun Liu; David R Gibb; Manjula Santhanakrishnan; Dong Liu; James E Forsmo; Stephanie C Eisenbarth; Ellen F Foxman; Sean R Stowell; Chance John Luckey; James C Zimring; Krystalyn E Hudson; Jeanne E Hendrickson
Journal:  Blood       Date:  2020-05-28       Impact factor: 25.476

10.  IgG Suppresses Antibody Responses to Sheep Red Blood Cells in Double Knock-Out Mice Lacking Complement Factor C3 and Activating Fcγ-Receptors.

Authors:  Jessica C Anania; Annika Westin; Birgitta Heyman
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.